Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8 » default
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
- View all (872)
- Volume 16, 2024 (25)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 8, 2016
Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication
Bonafede MMK, Curtis JR, McMorrow D, Mahajan P, Chen C
ClinicoEconomics and Outcomes Research 2016, 8:707-715
Published Date: 2 December 2016
Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe
Shamu S, Rusakaniko S, Hongoro C
ClinicoEconomics and Outcomes Research 2016, 8:695-705
Published Date: 24 November 2016
Patient-reported financial barriers to adherence to treatment in neurology
Moura LMVR, Schwamm EL, Moura Junior V, Seitz MP, Hoch DB, Hsu J, Schwamm LH
ClinicoEconomics and Outcomes Research 2016, 8:685-694
Published Date: 17 November 2016
Evaluating increased resource use in fibromyalgia using electronic health records
Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S
ClinicoEconomics and Outcomes Research 2016, 8:675-683
Published Date: 16 November 2016
UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD
Tebboth A, Ternouth A, Gonzalez-Rojas N
ClinicoEconomics and Outcomes Research 2016, 8:667-674
Published Date: 7 November 2016
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW
ClinicoEconomics and Outcomes Research 2016, 8:657-666
Published Date: 31 October 2016
Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2016, 8:649-655
Published Date: 25 October 2016
Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis
Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK
ClinicoEconomics and Outcomes Research 2016, 8:641-648
Published Date: 25 October 2016
Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow’s milk allergy in Brazil
Guest JF, Yang AC, Oba J, Rodrigues M, Caetano R, Polster L
ClinicoEconomics and Outcomes Research 2016, 8:629-639
Published Date: 19 October 2016
The direct health-care burden of valvular heart disease: evidence from US national survey data
Moore M, Chen J, Mallow PJ, Rizzo JA
ClinicoEconomics and Outcomes Research 2016, 8:613-627
Published Date: 18 October 2016
Bringing patient centricity to diabetes medication access in Canada
Glennie JL, Kovacs Burns K, Oh P
ClinicoEconomics and Outcomes Research 2016, 8:599-611
Published Date: 17 October 2016
Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2016, 8:591-597
Published Date: 14 October 2016
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J
ClinicoEconomics and Outcomes Research 2016, 8:583-590
Published Date: 12 October 2016
Methods to construct a step-by-step beginner’s guide to decision analytic cost-effectiveness modeling
Rautenberg T, Hulme C, Edlin R
ClinicoEconomics and Outcomes Research 2016, 8:573-581
Published Date: 11 October 2016
Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ
ClinicoEconomics and Outcomes Research 2016, 8:559-571
Published Date: 7 October 2016
Health and economic benefits of physical activity for patients with spinal cord injury
Miller LE, Herbert WG
ClinicoEconomics and Outcomes Research 2016, 8:551-558
Published Date: 3 October 2016
Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain
Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J
ClinicoEconomics and Outcomes Research 2016, 8:541-550
Published Date: 26 September 2016
Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis
Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F
ClinicoEconomics and Outcomes Research 2016, 8:531-540
Published Date: 22 September 2016
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
Permsuwan U, Dilokthornsakul P, Saokaew S, Thavorn K, Chaiyakunapruk N
ClinicoEconomics and Outcomes Research 2016, 8:521-529
Published Date: 21 September 2016
A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding
Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R
ClinicoEconomics and Outcomes Research 2016, 8:507-519
Published Date: 21 September 2016
Patient-level costs of major cardiovascular conditions: a review of the international literature
Nicholson G, Gandra SR, Halbert RJ, Richhariya A, Nordyke RJ
ClinicoEconomics and Outcomes Research 2016, 8:495-506
Published Date: 21 September 2016
Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J
ClinicoEconomics and Outcomes Research 2016, 8:485-493
Published Date: 19 September 2016
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D
ClinicoEconomics and Outcomes Research 2016, 8:475-484
Published Date: 21 September 2016
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G
ClinicoEconomics and Outcomes Research 2016, 8:467-473
Published Date: 14 September 2016
Cost analysis of magnetically controlled growing rods compared with traditional growing rods for early-onset scoliosis in the US: an integrated health care delivery system perspective
Polly Jr DW, Ackerman SJ, Schneider K, Pawelek JB, Akbarnia BA
ClinicoEconomics and Outcomes Research 2016, 8:457-465
Published Date: 14 September 2016
Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD
Ramos M, Haughney J, Henry N, Lindner L, Lamotte M
ClinicoEconomics and Outcomes Research 2016, 8:445-456
Published Date: 12 September 2016
A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions
Darbà J, Ramírez G, García-Rivero JL, Mayoralas-Alises S, Pascual JF, Roger A,Vargas D, Bijedic A
ClinicoEconomics and Outcomes Research 2016, 8:435-444
Published Date: 6 September 2016
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders
Thompson M, Henshall C, Garrison LP, Griffin AD, Coyle D, Long S, Khayat ZA, Anger DL, Yu R
ClinicoEconomics and Outcomes Research 2016, 8:427-433
Published Date: 26 August 2016
A systematic review of observational studies evaluating costs of adverse drug reactions
Batel Marques F, Penedones A, Mendes D, Alves C
ClinicoEconomics and Outcomes Research 2016, 8:413-426
Published Date: 24 August 2016
Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study
Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N
ClinicoEconomics and Outcomes Research 2016, 8:407-412
Published Date: 4 August 2016
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage III C and IV epithelial ovarian cancer
Forde GK, Chang J, Ziogas A
ClinicoEconomics and Outcomes Research 2016, 8:397-406
Published Date: 2 August 2016
The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database
Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W
ClinicoEconomics and Outcomes Research 2016, 8:387-395
Published Date: 2 August 2016
Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives
Croce D, Bonfanti M, Restelli U
ClinicoEconomics and Outcomes Research 2016, 8:377-385
Published Date: 8 August 2016
Work intensity in sacroiliac joint fusion and lumbar microdiscectomy
Frank C, Kondrashov D, Meyer SC, Dix G, Lorio M, Kovalsky D, Cher D
ClinicoEconomics and Outcomes Research 2016, 8:367-376
Published Date: 26 July 2016
Characterizing individual painDETECT symptoms by average pain severity
Sadosky A, Koduru V, Bienen EJ, Cappelleri JC
ClinicoEconomics and Outcomes Research 2016, 8:361-366
Published Date: 26 July 2016
Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approach
Ponzetti C, Canciani M, Farina M, Era S, Walzer S
ClinicoEconomics and Outcomes Research 2016, 8:353-359
Published Date: 3 August 2016
Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin [Erratum]
Wood DE, Lauer LM, Layton A, Tong KB
ClinicoEconomics and Outcomes Research 2016, 8:351-352
Published Date: 15 July 2016
Ignoring the sacroiliac joint in chronic low back pain is costly [Corrigendum]
Polly DW, Cher D
ClinicoEconomics and Outcomes Research 2016, 8:349-350
Published Date: 8 July 2016
Screening strategies for active tuberculosis: focus on cost-effectiveness
Dobler CC
ClinicoEconomics and Outcomes Research 2016, 8:335-347
Published Date: 30 June 2016
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer
Tremblay G, Livings C, Crowe L, Kapetanakis V, Briggs A
ClinicoEconomics and Outcomes Research 2016, 8:323-333
Published Date: 30 June 2016
The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact
De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G
ClinicoEconomics and Outcomes Research 2016, 8:317-322
Published Date: 29 June 2016
Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland
Guest JF, Weidlich D, Kaczmarski M, Jarocka-Cyrta E, Kobelska-Dubiel N, Krauze A, Sakowska-Maliszewska I, Zawadzka-Krajewska A
ClinicoEconomics and Outcomes Research 2016, 8:307-316
Published Date: 28 June 2016
Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]
Cher DJ, Frasco MA, Arnold RJG, Polly DW
ClinicoEconomics and Outcomes Research 2016, 8:305-306
Published Date: 27 June 2016
A structured review of health utility measures and elicitation in advanced/metastatic breast cancer
Hao Y, Wolfram V, Cook J
ClinicoEconomics and Outcomes Research 2016, 8:293-303
Published Date: 23 June 2016
Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?
Klag N, Walter AC, Sheely KM, Manahan KJ, Geisler JP
ClinicoEconomics and Outcomes Research 2016, 8:287-291
Published Date: 21 June 2016
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China
Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C
ClinicoEconomics and Outcomes Research 2016, 8:275-285
Published Date: 14 June 2016
A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample
Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G
ClinicoEconomics and Outcomes Research 2016, 8:267-274
Published Date: 13 June 2016
Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification
Menditto E, Bolufer de Gea A, Cahir C, Marengoni A, Riegler S, Fico G, Costa E, Monaco A, Pecorelli S, Pani L, Prados-Torres A
ClinicoEconomics and Outcomes Research 2016, 8:253-265
Published Date: 13 June 2016
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
Eklund O, Afzal F, Borgström F, Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M
ClinicoEconomics and Outcomes Research 2016, 8:243-252
Published Date: 11 June 2016
Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain
García Robaina JC, Polanco Sánchez C, Estella Pérez E
ClinicoEconomics and Outcomes Research 2016, 8:235-241
Published Date: 14 June 2016
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey
Ponzetti C, Canciani M, Farina M, Era S, Walzer S
ClinicoEconomics and Outcomes Research 2016, 8:227-233
Published Date: 23 May 2016
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS
ClinicoEconomics and Outcomes Research 2016, 8:215-226
Published Date: 20 May 2016
The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study
Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S
ClinicoEconomics and Outcomes Research 2016, 8:207-214
Published Date: 20 May 2016
Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable
Schmier JK, Hulme-Lowe CK, Semenova S, Klenk JA, DeLeo PC, Sedlak R, Carlson PA
ClinicoEconomics and Outcomes Research 2016, 8:197-205
Published Date: 13 May 2016
Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin
Wood DE, Lauer LM, Layton A, Tong KB
ClinicoEconomics and Outcomes Research 2016, 8:187-195
Published Date: 17 May 2016
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis
Guo A, Grabner M, Palli SR, Elder J, Sidovar M, Aupperle P, Krieger S
ClinicoEconomics and Outcomes Research 2016, 8:177-186
Published Date: 12 May 2016
The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
Dal Negro RW, Povero M
ClinicoEconomics and Outcomes Research 2016, 8:171-176
Published Date: 10 May 2016
Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system
Al-Ahmad M, Alowayesh MS, Carroll NV
ClinicoEconomics and Outcomes Research 2016, 8:163-169
Published Date: 10 May 2016
Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
Romanelli M, Gilligan AM, Waycaster CR, Dini V
ClinicoEconomics and Outcomes Research 2016, 8:153-161
Published Date: 4 May 2016
Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
Chen W, Yang Y, Chen Y, Du F, Zhan H
ClinicoEconomics and Outcomes Research 2016, 8:137-151
Published Date: 3 May 2016
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N
ClinicoEconomics and Outcomes Research 2016, 8:127-136
Published Date: 29 April 2016
A burden of illness study for neuropathic pain in Europe
Liedgens H, Obradovic M, De Courcy J, Holbrook T, Jakubanis R
ClinicoEconomics and Outcomes Research 2016, 8:113-126
Published Date: 27 April 2016
Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
Chen JH, Wu S, Hu C, Yang Y, Rajan N, Chen Y, Yang C, Li J, Chen W
ClinicoEconomics and Outcomes Research 2016, 8:97-111
Published Date: 26 April 2016
Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome
Fadda V, Maratea D
ClinicoEconomics and Outcomes Research 2016, 8:87-95
Published Date: 15 April 2016
Productivity benefits of minimally invasive surgery in patients with chronic sacroiliac joint dysfunction
Saavoss JD, Koenig L, Cher DJ
ClinicoEconomics and Outcomes Research 2016, 8:77-85
Published Date: 11 April 2016
Designing economic evaluations to facilitate optimal decisions: the need to avoid bias
Lee KM, Coyle K, Coyle D
ClinicoEconomics and Outcomes Research 2016, 8:73-76
Published Date: 5 April 2016
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China
Lesher B, Gao X, Chen Y, Liu Z
ClinicoEconomics and Outcomes Research 2016, 8:63-72
Published Date: 24 March 2016
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
Johnson BH, Bonafede MM, Watson C
ClinicoEconomics and Outcomes Research 2016, 8:53-61
Published Date: 23 February 2016
Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
Carron M, Baratto F, Zarantonello F, Ori C
ClinicoEconomics and Outcomes Research 2016, 8:43-52
Published Date: 18 February 2016
Costs associated with rheumatoid arthritis in Italy: past, present, and future
Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A
ClinicoEconomics and Outcomes Research 2016, 8:33-41
Published Date: 10 February 2016
Ignoring the sacroiliac joint in chronic low back pain is costly
Polly DW, Cher D
ClinicoEconomics and Outcomes Research 2016, 8:23-31
Published Date: 21 January 2016
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A
ClinicoEconomics and Outcomes Research 2016, 8:15-21
Published Date: 31 December 2015
Cost-effectiveness of minimally invasive sacroiliac joint fusion
Cher DJ, Frasco MA, Arnold RJG, Polly DW
ClinicoEconomics and Outcomes Research 2016, 8:1-14
Published Date: 18 December 2015